Oragenics Inc. Announces CMO Presentation at IPAC‑RS Nasal Forum

What Happened

• Oragenics, Inc. (OGEN) filed a Form 8‑K (Sept. 16, 2026) disclosing that its Chief Medical Officer, James P. Kelly, will present in the "Successful Case Studies" session at the IPAC‑RS 2026 Nasal Innovation Forum on Thursday, September 17, 2026.
• The company expects to use a presentation (filed as Exhibit 99.1) during that talk and issued a press release on September 16, 2026 (filed as Exhibit 99.2). The presentation will also be available on Oragenics’ website under News & Media → Presentations.

Key Details

• Event: IPAC‑RS 2026 Nasal Innovation Forum — "Successful Case Studies" session on Sept. 17, 2026.
• Speaker: James P. Kelly, Chief Medical Officer of Oragenics.
• Filings: Presentation attached as Exhibit 99.1 and press release attached as Exhibit 99.2 to the 8‑K filed Sept. 16, 2026.
• Disclosure note: Company states the Presentation is summary information and makes no admission as to materiality under Regulation FD; it has no obligation to update the materials.

Why It Matters

• This filing is a Regulation FD disclosure that makes the company’s presentation and press release broadly available to investors and the public. Retail investors can review the posted materials for any clinical or business updates presented by the CMO.
• The 8‑K itself does not report financial results or new material agreements; it primarily announces the timing and availability of the presentation and related press release.